What are the Area Under the Curve (AUC) values for Venous Thromboembolism (VTE)-BLEED, RIETE, VTE-PREDICT, CHA2DS2-VASc (CHAP), and Anti-Coagulant Bleeding (ABC)-bleeding scores?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

AUC Values for VTE Risk Scoring Systems

The PESI score has the highest documented AUC value of 0.87 for predicting 30-day mortality in pulmonary embolism patients, while the VTE-BLEED score has an AUC of 0.72-0.75 for predicting major bleeding events during stable anticoagulation. 1, 2

VTE-BLEED Score

  • VTE-BLEED was developed to predict bleeding events in patients on stable anticoagulation after venous thromboembolism 2
  • AUC of 0.72 (95% CI 0.67-0.76) for overall bleeding prediction during the complete follow-up period 2
  • For prediction of major bleeding after day 30 ("stable" anticoagulation):
    • AUC of 0.75 (95% CI 0.61-0.89) in patients on dabigatran
    • AUC of 0.78 (95% CI 0.68-0.86) in patients on warfarin 2
  • In the XALIA study validation, VTE-BLEED showed good predictive value for major bleeding after day 30 and day 90 3

RIETE Score

  • RIETE score was derived from the Registro Informatizado de la Enfermedad TromboEmbólica registry 1, 4
  • AUC ranging between 0.69 and 0.72 for predicting major bleeding across different time periods (first 30 days, days 31-90, days 91-180, and days 181-360) 4
  • Performs better for predicting early extracranial bleeding compared to intracranial hemorrhages 4

Comparison of VTE-BLEED and RIETE

  • Both scores showed similar performance with AUCs ranging between 0.69 and 0.72 across different time periods 4
  • RIETE score was more useful for early extracranial bleeding prediction 4
  • VTE-BLEED was more useful for late intracranial hemorrhage prediction 4
  • Positive predictive values for both scores were low (0.6-3.9%), being better for early major bleeding than for later periods 4

PESI and sPESI Scores

  • PESI (Pulmonary Embolism Severity Index) score:
    • AUC of 0.77 (95% CI 0.75 to 0.79) in internal validation 1
    • AUC of 0.87 in external validation for predicting 90-day mortality 1
  • sPESI (Simplified Pulmonary Embolism Severity Index):
    • Derived from RIETE registry data 1
    • Non-inferior to PESI in predicting 30-day mortality 1
    • Specific AUC value not provided in the available evidence 1

CHAP (CHA₂DS₂-VASc) Score

  • While mentioned in the question, specific AUC values for CHAP/CHA₂DS₂-VASc in VTE risk assessment were not provided in the available evidence
  • This score is primarily used for stroke risk assessment in atrial fibrillation patients 1

ABC-Bleeding Score

  • While mentioned in the question, specific AUC values for ABC-bleeding were not provided in the available evidence

VTE-PREDICT Score

  • While mentioned in the question, specific AUC values for VTE-PREDICT were not provided in the available evidence

Clinical Implications

  • When selecting a risk score, clinicians should consider the specific outcome they want to predict (mortality, bleeding, recurrent VTE) 5
  • The usefulness of available bleeding scores may vary depending on the patient population characteristics and the time frame evaluated 4
  • Dynamic scoring approaches that can be updated throughout treatment may be more useful than static scores assessed only at baseline 4
  • Most bleeding risk scores have only modest predictive value for patients with VTE 6

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.